NASDAQ:LMDXW

LumiraDx (LMDXW) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.0030
$0.0145
52-Week Range
N/A
Volume
333,900 shs
Average Volume
171,420 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About LumiraDx

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.

LMDXW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive LMDXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LumiraDx and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:LMDXW
Fax
N/A
Employees
1,210
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$126.52 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Ms. Veronique Ameye EMBA (Age 46)
    Esq., M.B.A., CEO & General Counsel
  • Mr. Dorian LeBlanc CPA (Age 48)
    CFO & VP of Global Operations
  • Ms. Colleen McMillen
    Vice President of Communications
  • Andy Ward
    National Sales Director - UK
  • Mr. David Walton DMS (Age 69)
    Chief Commercial Officer
  • Giffin Daughtridge
    President of North America Commercial Operations & Global Molecular Solutions
  • Melissa Garcia
    VP & Corporate Counsel

This page (NASDAQ:LMDXW) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners